Transfection Reagents and Equipment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Transfection Reagents and Equipment market is segmented by Product, Method, End User (Pharmaceutical & Biotechnology Companies, and Academics & Research Institutes), and Geography

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors that are driving the market growth include technological advancements in transfection, an increase in R&D expenditure and research activities by pharmaceutical and biotech companies, and a rise in demand for synthetic genes.

Introduction of transfection technologies has laid the foundation for genetic dissection of several causative agents of a number of diseases and recent years have seen the development of novel tools for genetic manipulation that will help the scientific community delineate the intriguing biology of a wide variety of parasites. Academic research trends continue to drive transfection technology advancements. 

Over the forecast period, researchers are expected to use more biologically relevant yet hard-to-transfect cell models in addition to the standard immortalized cell lines, along with a broader range of nucleic acids, such as RNA variants. These possibilities lead to interesting twists that demands innovation.

Scope of the Report

As per the scope of the report, transfection refers to the process of artificially introducing nucleic acids (DNA or RNA) into eukaryotic cells. Such introductions of foreign nucleic acid using various chemical, biological, or physical methods can result in a change of the properties of the cell, allowing the study of gene function and protein expression in the context of the cell. The reagents and equipment used in this procedure are referred to as transfection reagents and equipment.

By Product
Reagents
Equipment
By Method
Biochemical Methods
Physical Methods
Viral Methods
By End User
Pharmaceutical & Biotechnology Companies
Academics & Research Institutes
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Rest of the World

Report scope can be customized per your requirements. Click here.

Key Market Trends

Pharmaceutical & Biotechnology Companies are Expected to Hold a Significant Share in the End User Segment

The rapid progress of cell and gene therapies through clinical development is fueling the demand for late-stage clinical and commercial manufacturing capabilities. Transient transfection for vector production offers noteworthy flexibility for cell and gene therapy development. Pharmaceutical and biotechnology companies with the ability to achieve high-yielding clinical and commercial manufacturing of high-quality viral vectors using transient transfection are now offering their clients this flexibility combined with scalability and speed to market.

Moreover, the global pharmaceutical industry investment in research and development has increased over the years, Hence, with the increasing R&D expenditure, the market in the pharmaceutical industry is expected to attain a good growth over the forecast period.

Graph.png

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the global market studied. Research in the region, especially in the United States, is widely believed to be essential to the economic growth of North America, and the innovations derived from basic and applied research provide enormous benefits to society. For this reason, the federal government devotes a significant amount of funding towards biopharmaceutical products research. Hence, the US is expected to dominate the global market over the forecast period as well.

Geo.png

Competitive Landscape

The global transfection reagents and Equipment market is moderately competitive and consists of a number of major players. Companies like Bio-Rad Laboratories, Lonza Group, MaxCyte Inc., Merck KGaA, Mirus Bio, Polyplus-transfection SA, Promega Corporation, QIAGEN N.V., Thermo Fisher Scientific Inc.., among others, hold the substantial market share in the Transfection Reagents and Equipment market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Transfection

      2. 4.2.2 Increase in R&D Expenditure and Research Activities by Pharmaceutical and Biotech Companies

      3. 4.2.3 Rise in Demand for Synthetic Genes

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Transfection Reagents

      2. 4.3.2 Selective Effectiveness and Certain Limitations of Transfection Reagents

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Reagents

      2. 5.1.2 Equipment

    2. 5.2 By Method

      1. 5.2.1 Biochemical Methods

      2. 5.2.2 Physical Methods

      3. 5.2.3 Viral Methods

    3. 5.3 By End User

      1. 5.3.1 Pharmaceutical & Biotechnology Companies

      2. 5.3.2 Academics & Research Institutes

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Rest of the World

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bio-Rad Laboratories, Inc.

      2. 6.1.2 Lonza Group

      3. 6.1.3 MaxCyte Inc.

      4. 6.1.4 Merck KGaA

      5. 6.1.5 Mirus Bio LLC

      6. 6.1.6 Polyplus-transfection SA

      7. 6.1.7 Promega Corporation

      8. 6.1.8 Qiagen N.V.

      9. 6.1.9 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Transfection Reagents and Equipment Market market is studied from 2018 - 2026.

The Transfection Reagents and Equipment Market is growing at a CAGR of 7.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Bio-Rad Laboratories, Polyplus-transfection SA, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific are the major companies operating in Transfection Reagents and Equipment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!